Evolv Technologies Holdings, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Net Loss per Share (Tables)

Net Loss per Share (Tables)

12 Months Ended

Dec. 31, 2021

Net Loss per Share

Schedule of basic and diluted net loss per share attributable to common stockholders


		Year Ended December 31,
		2021			2020
Numerator:
Net loss attributable to common stockholders – basic and diluted		$	(10,858)		$	(27,392)

Denominator:
Weighted average common shares outstanding — basic and diluted			71,662,694			8,932,404
Net loss per share attributable to common stockholders - basic diluted		$	(0.15)		$	(3.07)

Schedule of potential common shares excluded from the computation of diluted net loss per share


		Year Ended December 31,
		2021		2020
Options issued and outstanding		20,769,130		18,770,767
Public Warrants to purchase common stock		14,324,994		—
Convertible preferred stock (as converted to common stock)		—		80,833,007
Warrants to purchase preferred stock (as converted to warrants to purchase common stock)		—		1,014,963
Warrants to purchase common stock		—		922,297
Warrants to purchase common stock (Finback)**		2,269,017		—
Unvested restricted stock units		1,951,924		—
Earn-out shares**		15,000,000		—
Contingently issuable common stock**		1,897,500		—
Convertible notes (as converted to common stock)*		—		1,192,469
		56,212,565		102,733,503